Epidemic obesity and type 2 diabetes in Asia.

By K. Yoon, Jin-Hee Lee, Ji-Won Kim, Jae-Hyoung Cho, Yoon-Hee Choi, Seung-Hyun Ko, P. Zimmet, Ho-Young Son. The Lancet, 2006

1,606 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Risk Factors Contributing to Type 2 Diabetes and Recent Advances in the Treatment and Prevention (2014, background): “Rosiglitazone and troglitazone have been withdrawn from the market considering the increased risk of myocardial infarction [106] and idiosyncratic hepatotoxicity [107], respectively.”
Global incidence and prevalence of nonalcoholic fatty liver disease (2022, background): “Asians also tend to develop diabetes at a younger age and lower BMI level, resulting in a longer duration of disease and increased likelihood of complications(27-29).”
The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives (2012, background): “The 'metabolically obese' phenotype might also explain the mismatch between the rates of obesity and T2DM in Asia”
Globalization of Diabetes (2011, background): “In Asian populations, increased risk of diabetes starts at a lower BMI than in Europeans (9).”
Does wheat make us fat and sick (2013, background): “Moreover, the proliferation of wheat products has a much longer history than the much more recent drastic increases in occurrence of obesity, which has also occurred in populations that eat little wheat, such as several Asian countries (Yoon et al., 2006).”